chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Vaccination site erythema, Vaccination site swelling
Clinical narrative: nausea; joint pain; injection site very red and swollen; injection site very red and swollen; Throat and mouth felt swollen and very dry; Throat and mouth felt swollen and very dry; Throat and mouth felt swollen and very dry; Throat and mouth felt swollen and very dry; head ached; felt out of sorts; left arm kept going numb; eyelids were heavy; Swollen gland; This is a spontaneous report from a contactable consumer (patient) reporting for herself.    A 68-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 20Feb2021 13:00 as DOSE 1, SINGLE for covid-19 immunisation (age at vaccination 68 years). Medical history included asthma and allergies from an unknown date and unknown if ongoing. Concomitant medications included vitamins and thyroid medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient experienced nausea, joint pain, injection site very red and swollen, throat and mouth felt swollen and very dry, head ached, felt out of sorts, left arm kept going numb, eyelids were heavy, swollen gland on 20Feb2021 23:00. Reporter stated that, later that night at bedtime, started with nausea, joint pain, injection site very red and swollen, then my throat and mouth felt swollen and very dry as if someone put a wad of cotton down my throat. My head ached and felt out of sorts. My left arm kept going numb. My eyelids were heavy. Swollen gland. This intensity continued for 5 days, and still had some side effects now, 3 weeks later. Therapeutic measures taken as a result of the events included started taking antihistamines. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: My shoulder feels like it is going to fall off.; This is a spontaneous report from a non-contactable consumer or other non hcp. A 35-year-old non-pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Lot number was unknown), via an unspecified route of administration, administered in Arm Left on 09Mar2021 10:30 (at the age of 35-year-old) as dose 1, single for COVID-19 immunisation. Medical history included allergy with Sulfonamide Derivates, Cephalosporins and Sulfa Antibiotics. Patient did not receive other vaccine in four weeks. Patient received medications in two weeks. Patient did not receive covid prior vaccination. On 09Mar2021 13:30, the patient experienced my shoulder feels like it is going to fall off. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Sore Left Arm; Left Arm joint ache; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6199), via an unspecified route of administration, administered in arm left on 13Mar2021 (at the age of 57-years-old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccine was administered at the Pharmacy/Drugstore. The patient medical history included type 1 diabetes from an unknown date. Concomitant medications included levothyroxine sodium (LEVOXYL); insulin lispro (HUMALOG); and insulin glargine (LANTUS); all were taken for an unspecified indication, start and stop date were not reported. On 13Mar2021, the patient experienced sore left arm and left arm joint ache. The outcome of the events was recovered with no treatment received.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; muscle aches; fever; nauseous; fatigue; This is a spontaneous report from a contactable consumer. A 55-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number, Expiration date was not provided) via an unspecified route of administration in the left arm, 10Mar2021 at 10:00 (age at vaccination 55-years) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no known allergies. On 11mar2021 the patient experienced sore throat, muscle aches, fever, nauseous and fatigue. Patient had covid prior vaccination. Patient was not tested for Covid post vaccination. The patient did not receive any treatment. The outcome of events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: rash that itches around the neck area; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 77-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 10Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (penicillin) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. It was reported that, Starting yesterday or the day before (Mar2021), the patient was experiencing a rash that itches around the neck area. Patient second injection was scheduled on 31Mar2021, the same day she have some eye surgery scheduled. The patient was asking will that be ok. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itching; rash with hives on left arm, shoulder chest and up her neck on left side; This is a spontaneous report from a contactable Nurse (reported for herself). A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 28Feb2021 (at the age of 68-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 01Mar2021, the reporter reported that, she experienced itching, and a rash with hives on left arm, shoulder chest and up her neck on left side. She applied hydrocortisone cream and took Benadryl. The next morning used the hydrocortisone cream again after her shower since the rash came back. The reporter requesting to take the second vaccine. Her doctor said it was up to her but to take Zyrtec the day before and the day of the second dose. Therapeutic measures were taken as a result of events included treatment with Hydrocortisone cream and Benadryl. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Discomfort, Irritability, Musculoskeletal stiffness, Myalgia
Clinical narrative: unease and irritation, similar to what steroids can cause; irritation/rash started on my right forearm (shot was in left arm); minor burning; itching; very bad muscle pain; stiffness at shot location; very uncomfortable; radiating to between shoulder blades, and up into neck. On a 1-10 scale of pain, about 8.5.; This is a spontaneous report from a contactable Consumer or other non-health care professional (Patient). A 66-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch no /lot number: not reported) via an unspecified route of administration in arm left on 10Mar2021 10:00 AM (at the age vaccination of 66-year-old) as dose 2, single for cvis019 immunization. Patient's medical history included seasonal allergies and Concomitant medications included other medications in two weeks as finasteride (FINASTERIDE), meso zeaxanthin, xantofyl, zeaxanthin (MACUHEALTH WITH LMZ3) and Mediherb thyroid complex all were taken for an unspecified indication from an unknown start and stop date. Historical vaccine included patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch no /lot number: not reported) via an unspecified route of administration in right arm on 17Feb2021 10:00 AM (at the age vaccination of 66-year-old) as dose 1, single for COVID-19 immunization, no issues with first shot. Patient did not receive other vaccine within four weeks of vaccination. Patient did not have COVID-19 prior to vaccination and not tested for COVID-19 post vaccination. It was reported that patient had no issues with first shot and with the second shot, nothing was life threatening. On 11Mar2021 08:00 AM patient experienced with very uncomfortable, very bad muscle pain and stiffness at shot location, radiating to between shoulder blades, and up into neck. On a 1-10 scale of pain, about 8.5, which were started less than 24 hours after 2nd shot. At about 48 hours an irritation/rash started on his right forearm (shot was in left arm). The site was about 1" wide by 6" long and persisted with minor burning and itching for about 24 hours. On the 3rd day after the 2nd shot, he also felt a lot of unease and irritation, similar to what steroids can cause, which lasted a couple of days. Patient did not receive any treatment for the events reported. Outcome of the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. No further information expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain assessment, Pruritus, Rash
Clinical narrative: unease and irritation, similar to what steroids can cause; irritation/rash started on my right forearm (shot was in left arm); minor burning; itching; very bad muscle pain; stiffness at shot location; very uncomfortable; radiating to between shoulder blades, and up into neck. On a 1-10 scale of pain, about 8.5.; This is a spontaneous report from a contactable Consumer or other non-health care professional (Patient). A 66-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch no /lot number: not reported) via an unspecified route of administration in arm left on 10Mar2021 10:00 AM (at the age vaccination of 66-year-old) as dose 2, single for cvis019 immunization. Patient's medical history included seasonal allergies and Concomitant medications included other medications in two weeks as finasteride (FINASTERIDE), meso zeaxanthin, xantofyl, zeaxanthin (MACUHEALTH WITH LMZ3) and Mediherb thyroid complex all were taken for an unspecified indication from an unknown start and stop date. Historical vaccine included patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch no /lot number: not reported) via an unspecified route of administration in right arm on 17Feb2021 10:00 AM (at the age vaccination of 66-year-old) as dose 1, single for COVID-19 immunization, no issues with first shot. Patient did not receive other vaccine within four weeks of vaccination. Patient did not have COVID-19 prior to vaccination and not tested for COVID-19 post vaccination. It was reported that patient had no issues with first shot and with the second shot, nothing was life threatening. On 11Mar2021 08:00 AM patient experienced with very uncomfortable, very bad muscle pain and stiffness at shot location, radiating to between shoulder blades, and up into neck. On a 1-10 scale of pain, about 8.5, which were started less than 24 hours after 2nd shot. At about 48 hours an irritation/rash started on his right forearm (shot was in left arm). The site was about 1" wide by 6" long and persisted with minor burning and itching for about 24 hours. On the 3rd day after the 2nd shot, he also felt a lot of unease and irritation, similar to what steroids can cause, which lasted a couple of days. Patient did not receive any treatment for the events reported. Outcome of the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Breast pain, Breast tenderness, Chest discomfort, Tenderness
Clinical narrative: a lot of soreness and tenderness at the site of my breast cancer surgery (right side of my body); a lot of soreness and tenderness at the site of my breast cancer surgery (right side of my body); felt a tender lump at that site; feel lingering tightness; tenderness I felt after my shot seemed to be centered between the two scars (lymph nodes and one for the tumor); This is a spontaneous report from a contactable consumer (patient).  A 68-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via unknown route of administration at left arm on 08Mar2021 at 12:45 pm (age at vaccination 68-year-old) as dose 1, single for COVID-19 immunisation at Public Health Clinic/Military Administration facility. The patient known allergy included nickel allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient medical history included recovered from breast cancer, 3 lymph nodes under this arm were surgically removed 3 years ago/breast cancer and breast cancer surgery on an unknown date. The patient concomitant medications (other medication) included Letrozole 2.5 mg in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021 at 11:00 pm, the patient woke up and had a lot of soreness and tenderness at the site of my breast cancer surgery (right side of my body). This is unusual. I might only experience such a sensation similar to this if I touched the scar tissue continuously and with a lot of pressure. The tenderness I felt after my shot seemed to be centered between the two scars (lymph nodes and one for the tumor) and was constant. The sensation was similar to what I felt when my incisions were just starting to heal. I also felt a tender lump at that site. The "lump", tenderness and soreness have since gone away. It lasted a bit more than 12 hours. I still feel lingering tightness. The patient was informed that swelling of lymph nodes in the arm of injection is common after vaccination but, this was the opposite side. The patient did not received treatment for the events. The outcome of the event feel lingering tightness was not recovered, and other events was recovered with sequel on Mar2021  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Fatigue, Headache
Clinical narrative: Fever (100+); body & joint aches; body & joint aches; headache; slight nausea; weakness; extreme fatigue; feeling unwell; muscle pain; injection site pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A non-pregnant female patient of (Age: 72, Unit: unknown) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in arm right on 13Mar2021 at 14:00 (02:00 PM) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient received concomitant medications in two weeks which included metformin; glipizide; triamterene; irbesartan, all drugs taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in arm left on an unspecified date in Feb2021 at 02:00 PM as dose 1, single for COVID-19 immunization. On 13Mar2021 at 19:00 (07:00 PM), the patient experienced fever (100+), body and joint aches, headache, slight nausea, weakness, extreme fatigue, feeling unwell, muscle pain, injection site pain. Began 5-6 hrs after injection. Lasted 36+ hours and began to subside on Monday after injection. The patient underwent lab tests and procedures which included fever was 100+ on 13Mar2021. The patient did not receive treatment medication for all the events. Outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Fever (100+); body & joint aches; body & joint aches; headache; slight nausea; weakness; extreme fatigue; feeling unwell; muscle pain; injection site pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A non-pregnant female patient of (Age: 72, Unit: unknown) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in arm right on 13Mar2021 at 14:00 (02:00 PM) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient received concomitant medications in two weeks which included metformin; glipizide; triamterene; irbesartan, all drugs taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in arm left on an unspecified date in Feb2021 at 02:00 PM as dose 1, single for COVID-19 immunization. On 13Mar2021 at 19:00 (07:00 PM), the patient experienced fever (100+), body and joint aches, headache, slight nausea, weakness, extreme fatigue, feeling unwell, muscle pain, injection site pain. Began 5-6 hrs after injection. Lasted 36+ hours and began to subside on Monday after injection. The patient underwent lab tests and procedures which included fever was 100+ on 13Mar2021. The patient did not receive treatment medication for all the events. Outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever (100+); body & joint aches; body & joint aches; headache; slight nausea; weakness; extreme fatigue; feeling unwell; muscle pain; injection site pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A non-pregnant female patient of (Age: 72, Unit: unknown) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in arm right on 13Mar2021 at 14:00 (02:00 PM) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient received concomitant medications in two weeks which included metformin; glipizide; triamterene; irbesartan, all drugs taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in arm left on an unspecified date in Feb2021 at 02:00 PM as dose 1, single for COVID-19 immunization. On 13Mar2021 at 19:00 (07:00 PM), the patient experienced fever (100+), body and joint aches, headache, slight nausea, weakness, extreme fatigue, feeling unwell, muscle pain, injection site pain. Began 5-6 hrs after injection. Lasted 36+ hours and began to subside on Monday after injection. The patient underwent lab tests and procedures which included fever was 100+ on 13Mar2021. The patient did not receive treatment medication for all the events. Outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Diarrhoea, Fatigue
Clinical narrative: The injection site was bruised; burning sensation; when the vaccine went into my arm to the point where my eyes watered; goosebumps; violently throwing up; extreme chills; diarrhea; uncontrollable shakes; muscle joint aches; muscle joint aches; extremely tired; fingers were very very cold; This is a spontaneous report received from a contactable consumer (patient).   A 51-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EN6204) via an unspecified route of administration at left arm on 04Mar2021 12:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation. Medical history included High blood pressure, Cholesterol medication, Penicillin allergy, Known Allergies_Kiwis. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks. Patient do not have COVID-19 prior vaccination and since the vaccination. patient has not been tested for COVID-19. Patient receive other medications in 2 weeks of time as High blood pressure, Cholesterol medication. The patient experienced the injection site was bruised, burning sensation, when the vaccine went into my arm to the point where my eyes watered, goosebumps, violently throwing up, extreme chills, diarrhea, uncontrollable shakes, muscle joint aches, extremely tired, fingers were very very cold on 04Mar2021 14:00. Outcome of all events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Ocular discomfort, Peripheral coldness, Piloerection, Tremor
Clinical narrative: The injection site was bruised; burning sensation; when the vaccine went into my arm to the point where my eyes watered; goosebumps; violently throwing up; extreme chills; diarrhea; uncontrollable shakes; muscle joint aches; muscle joint aches; extremely tired; fingers were very very cold; This is a spontaneous report received from a contactable consumer (patient).   A 51-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EN6204) via an unspecified route of administration at left arm on 04Mar2021 12:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation. Medical history included High blood pressure, Cholesterol medication, Penicillin allergy, Known Allergies_Kiwis. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks. Patient do not have COVID-19 prior vaccination and since the vaccination. patient has not been tested for COVID-19. Patient receive other medications in 2 weeks of time as High blood pressure, Cholesterol medication. The patient experienced the injection site was bruised, burning sensation, when the vaccine went into my arm to the point where my eyes watered, goosebumps, violently throwing up, extreme chills, diarrhea, uncontrollable shakes, muscle joint aches, extremely tired, fingers were very very cold on 04Mar2021 14:00. Outcome of all events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vomiting
Clinical narrative: The injection site was bruised; burning sensation; when the vaccine went into my arm to the point where my eyes watered; goosebumps; violently throwing up; extreme chills; diarrhea; uncontrollable shakes; muscle joint aches; muscle joint aches; extremely tired; fingers were very very cold; This is a spontaneous report received from a contactable consumer (patient).   A 51-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EN6204) via an unspecified route of administration at left arm on 04Mar2021 12:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation. Medical history included High blood pressure, Cholesterol medication, Penicillin allergy, Known Allergies_Kiwis. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks. Patient do not have COVID-19 prior vaccination and since the vaccination. patient has not been tested for COVID-19. Patient receive other medications in 2 weeks of time as High blood pressure, Cholesterol medication. The patient experienced the injection site was bruised, burning sensation, when the vaccine went into my arm to the point where my eyes watered, goosebumps, violently throwing up, extreme chills, diarrhea, uncontrollable shakes, muscle joint aches, extremely tired, fingers were very very cold on 04Mar2021 14:00. Outcome of all events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Musculoskeletal pain, Vaccination site pain
Clinical narrative: Extreme exhaustion / fatigue; diarrhea; pain an swelling around injection site radiating to right shoulder blade; pain an swelling around injection site radiating to right shoulder blade; pain an swelling around injection site radiating to right shoulder blade; difficulty breathing; This is a spontaneous report from a contactable consumer (patient).  A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in right arm on 13Mar2021 at 09:30 (at the age of 55-years) as dose 1, single for covid-19 immunization at a hospital. The patient medical history included diabetes mellitus, hypertension. The patient was not pregnant at the time of vaccination. The patient had known allergies to drug metronidazole. The patient had not received any other vaccine within 4 weeks. The patient had received other medications in two weeks (unspecified). On 13Mar2021 10:45 the patient had experienced extreme exhaustion / fatigue, diarrhea, pain an swelling around injection site radiating to right shoulder blade, difficulty breathing. The patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was recovering on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Extreme exhaustion / fatigue; diarrhea; pain an swelling around injection site radiating to right shoulder blade; pain an swelling around injection site radiating to right shoulder blade; pain an swelling around injection site radiating to right shoulder blade; difficulty breathing; This is a spontaneous report from a contactable consumer (patient).  A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in right arm on 13Mar2021 at 09:30 (at the age of 55-years) as dose 1, single for covid-19 immunization at a hospital. The patient medical history included diabetes mellitus, hypertension. The patient was not pregnant at the time of vaccination. The patient had known allergies to drug metronidazole. The patient had not received any other vaccine within 4 weeks. The patient had received other medications in two weeks (unspecified). On 13Mar2021 10:45 the patient had experienced extreme exhaustion / fatigue, diarrhea, pain an swelling around injection site radiating to right shoulder blade, difficulty breathing. The patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was recovering on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Oropharyngeal pain, Pain, Psychomotor hyperactivity
Clinical narrative: streaks of dull pain and it seems to move through my upper body (hips, neck, arms, and back) at different times of the day; my body and joints started aching; my body and joints started aching; have a sore throat; I felt wide awake and did not go to bed until 2 a.m.; It felt like I drank lots of caffeine and I was hyper; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 48 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Mar2021 15:00 (Batch/Lot Number: EN6208) as DOSE 1, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced that she felt wide awake and did not go to bed until 2 a.m. causing insomnia on 08Mar2021 with outcome of not recovered, it felt like she drank lots of caffeine and she was hyper causing psychomotor hyperactivity on 08Mar2021 with outcome of not recovered, have a sore throat causing oropharyngeal pain on 10Mar2021 08:00 with outcome of recovered, her body and joints started aching on 11Mar2021 with outcome of not recovered, her body and joints started aching causing arthralgia on 11Mar2021 with outcome of not recovered, streaks of dull pain and it seems to move through the upper body hips, neck, arms, and back at different times of the day on 11Mar2021 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 11Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: streaks of dull pain and it seems to move through my upper body (hips, neck, arms, and back) at different times of the day; my body and joints started aching; my body and joints started aching; have a sore throat; I felt wide awake and did not go to bed until 2 a.m.; It felt like I drank lots of caffeine and I was hyper; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 48 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Mar2021 15:00 (Batch/Lot Number: EN6208) as DOSE 1, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced that she felt wide awake and did not go to bed until 2 a.m. causing insomnia on 08Mar2021 with outcome of not recovered, it felt like she drank lots of caffeine and she was hyper causing psychomotor hyperactivity on 08Mar2021 with outcome of not recovered, have a sore throat causing oropharyngeal pain on 10Mar2021 08:00 with outcome of recovered, her body and joints started aching on 11Mar2021 with outcome of not recovered, her body and joints started aching causing arthralgia on 11Mar2021 with outcome of not recovered, streaks of dull pain and it seems to move through the upper body hips, neck, arms, and back at different times of the day on 11Mar2021 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 11Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Chills; Temp up to 101.40 degrees; headache; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 72-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6206), via an unspecified route of administration, administered in Left Arm on 12Mar2021 (age at the time of vaccination was 72 years) at 08:30 as dose 2, single for covid-19 immunisation. Medical history included liver transplant, immunosuppressed and diabetes type2 all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported and known allergies were reported as no. Historically the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809), via an unspecified route of administration, administered in Left Arm on 16Feb2021 (age at the time of vaccination was 72 years) at 09:30 as dose 1, single for covid-19 immunisation. Reportedly the patient did not have covid prior vaccination. On 13Mar2021 at 12:00, the patient experienced chills, temp up to 101.40 degrees and headache. It was reported that, 25 hours, next day after vaccine, Chills, Temp up to 101.40 degrees, headache for 12 hours, and it returned to normal next day, except took two days (48 hours) for headache to subside. On an unspecified date, the patient underwent lab tests and procedures which included body Temp up to: 101.40 fahrenheit (Temp up to 101.40 degrees). Therapeutic measures were taken as a result of chills, temp up to 101.40 degrees and headache which included treatment with Ibuproben, & bed rest until next morning. The patient was not tested for covid post vaccination.  The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Sneezing
Clinical narrative: nose is congested; headache; sneezing; This is a spontaneous report from a contactable consumer (patient) from the Pfizer-sponsored program. A female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered anatomical location not reported, on 01Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. In Mar2021, the patient nose was congested, had headache and also sneezing after the first dose. The patient was asking if she could take colds and flu medicine and pain relievers. The outcome of the events was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Headache, Heart rate increased, Hypertension, Hypoaesthesia oral
Clinical narrative: tingly numb lips; tingly numb lips; headache; difficulty swallowing; Whole head later got tingly; High blood pressure and heart rate; High blood pressure and heart rate; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 15Mar2021 at 16:00 (at the age of 52-years-old) as single dose for COVID-19 immunization. The Patient was not pregnant at the time of vaccination. The Patient Medical history included skin cancer removal from an unknown date and unknown if ongoing. The patient's concomitant (two weeks prior vaccination) medications antibiotic (4 days) due to skin cancer removal. Patient not diagnosed with covid-19 prior to vaccination. The Patient had no known allergies. Patient received other medications in two weeks 4 days of antibiotic due to skin cancer removal. Patient was not received any other vaccine four weeks prior vaccination. On 15Mar2021 16:45, the patient experienced with tingly numb lips then headache, difficulty swallowing, Whole head later got tingly, High blood pressure and heart rate. Went to urgent care they wanted her to go to ER. Since vaccination patient not tested for covid-19. Event resulted to visit Emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Outcome of the events was reported as recovering.   No follow-up attempts are Possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: tingly numb lips; tingly numb lips; headache; difficulty swallowing; Whole head later got tingly; High blood pressure and heart rate; High blood pressure and heart rate; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 15Mar2021 at 16:00 (at the age of 52-years-old) as single dose for COVID-19 immunization. The Patient was not pregnant at the time of vaccination. The Patient Medical history included skin cancer removal from an unknown date and unknown if ongoing. The patient's concomitant (two weeks prior vaccination) medications antibiotic (4 days) due to skin cancer removal. Patient not diagnosed with covid-19 prior to vaccination. The Patient had no known allergies. Patient received other medications in two weeks 4 days of antibiotic due to skin cancer removal. Patient was not received any other vaccine four weeks prior vaccination. On 15Mar2021 16:45, the patient experienced with tingly numb lips then headache, difficulty swallowing, Whole head later got tingly, High blood pressure and heart rate. Went to urgent care they wanted her to go to ER. Since vaccination patient not tested for covid-19. Event resulted to visit Emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Outcome of the events was reported as recovering.   No follow-up attempts are Possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Illness, Movement disorder
Clinical narrative: fever/Fever of 101.5; headache so bad I couldn't move or even sit-up; headache so bad I couldn't move or even sit-up; aches; chills; I'm currently still ill at 84 hours.; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 66-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6204), via an unspecified route of administration (at the age of 66-years), administered in arm left on 12Mar2021 at 10:30 as dose 2, single for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medications included lisinopril (LISINOPRIL), hydrochlorothiazide (HYDROCHLOROTHIAZIDE), atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN9581), via an unspecified route of administration (at the age of 66-years), administered in arm left on 19Feb2021 at 00:30 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and it was unknown that the patient had been tested for covid post vaccination. The patient had no known allergies. The facility type vaccine was reported as other. The facility type vaccine other was reported as senior center. On an unspecified date in Mar2021, the patient experienced fever/fever of 101.5, headache so bad i couldn't move or even sit-up, aches, chills, I am currently still ill at 84 hours. It was further reported that 30 hours after the 2nd shot I developed a fever, chills, aches. Improved by 48 hours. Then it hit the fan at 54 hours. Fever of 101.5, headache so bad I could not move or even sit-up, aches and chills. This has continued for over a day. I am currently still ill at 84 hours. The treatment was not received for all the adverse events. The patient underwent lab tests and procedures which included body temperature: 101.5 on an unspecified date Fever of 101.5. The clinical outcome for all the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: fever/Fever of 101.5; headache so bad I couldn't move or even sit-up; headache so bad I couldn't move or even sit-up; aches; chills; I'm currently still ill at 84 hours.; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 66-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6204), via an unspecified route of administration (at the age of 66-years), administered in arm left on 12Mar2021 at 10:30 as dose 2, single for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medications included lisinopril (LISINOPRIL), hydrochlorothiazide (HYDROCHLOROTHIAZIDE), atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN9581), via an unspecified route of administration (at the age of 66-years), administered in arm left on 19Feb2021 at 00:30 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and it was unknown that the patient had been tested for covid post vaccination. The patient had no known allergies. The facility type vaccine was reported as other. The facility type vaccine other was reported as senior center. On an unspecified date in Mar2021, the patient experienced fever/fever of 101.5, headache so bad i couldn't move or even sit-up, aches, chills, I am currently still ill at 84 hours. It was further reported that 30 hours after the 2nd shot I developed a fever, chills, aches. Improved by 48 hours. Then it hit the fan at 54 hours. Fever of 101.5, headache so bad I could not move or even sit-up, aches and chills. This has continued for over a day. I am currently still ill at 84 hours. The treatment was not received for all the adverse events. The patient underwent lab tests and procedures which included body temperature: 101.5 on an unspecified date Fever of 101.5. The clinical outcome for all the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: My eyelids swelled up a few hours after injection and have stayed swollen.; This is a spontaneous report from a contactable Consumer. This Consumer reported for a male patient (Reporter's partner). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced my eyelids swelled up a few hours after injection and have stayed swollen on an unspecified date. This happened after his first shot. Outcome of the event was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Fatigue, Headache
Clinical narrative: complete loss of taste and smell; complete loss of taste and smell; severe aching all over; chills; fever; severe headache; vomiting; nausea; severe fatigue; This is a spontaneous report from a contactable consumer (patient).A 51-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in right arm on 12Mar2021 at 15:15 (at the age of 51-years) as dose 1, single for covid-19 immunization. The patient received Facility type vaccine at Public Health Clinic/ Administration facility. The patient medical history included degenerative disc disease. The patient had known allergies to Penicillin. The patient was not pregnant at the time of vaccination. The patient's Concomitant medications included clarithromycin (CLARITIN [CLARITHROMYCIN]); ibuprofen (IBUPROFEN); ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY); Iron Supplement. The patient had not received any other vaccine within 4 weeks. One day following vaccination on 13Mar2021 at 17:30, the patient had experienced severe aching all over, chills, fever, severe headache, vomiting, nausea, severe fatigue. Two days following vaccination on 14Mar2021, the patient also had complete loss of taste and smell. Three days following vaccination, headache, loss of taste and smell continued. The patient had not received any treatment for the events. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.